c-Myc can regulate the growth, proliferation, and metastasis of bladder cancer cells [26–28], and in addition, lowering c-Myc levels can reduce the resistance of bladder cancer cells to cisplatin [29]. The gene discussed is MYC; the disease is urinary bladder carcinoma.